Aehr Test Systems — FY2014 Form 10-K
Reporting period: Fiscal year ended May 31, 2014. This is an annual report, not a standalone quarterly filing; the filing also reports unaudited fourth-quarter results.
Business context
Aehr designs, manufactures and sells semiconductor test and burn-in equipment, including ABTS packaged-device systems and FOX wafer-level systems, plus WaferPak contactors, DiePak carriers and related products. The company reported one business segment and more than 2,500 systems installed worldwide.
Financial performance and liquidity
| Metric | FY2014 | FY2013 |
|---|---|---|
| Net sales | $19.684 million | $16.488 million |
| Gross profit / margin | $10.222 million / 51.9% | $6.776 million / 41.1% |
| Operating income (loss) | $0.497 million | $(3.307) million |
| Net income (loss) | $0.422 million | $(3.419) million |
| Net income (loss) per diluted share | $0.04 | $(0.36) |
| Cash from operating activities | $(0.607) million | $(0.310) million |
- Sales increased 19.4%, primarily from wafer-level products, whose sales were $8.3 million, up approximately $3.2 million year over year. Gross margin improved mainly because certain systems used materials written down in prior periods.
- Fourth-quarter FY2014 sales were $5.370 million, gross profit was $2.914 million and net income was $0.239 million, or $0.02 per share. In fourth-quarter FY2013, sales were $3.262 million and net loss was $0.854 million, or $0.08 per share.
- Cash and cash equivalents were $1.809 million at year-end, down from $2.324 million. Working capital was $6.556 million, up from $4.821 million; total assets were $12.225 million and shareholders’ equity was $7.029 million.
- The company had $0.777 million drawn on its asset-backed credit line, with $1.566 million available at May 31, 2014. The filing reports a 4.14% weighted-average rate and covenant compliance. A subsequent August 22, 2014 amendment extended the facility through August 21, 2015.
- Operating cash use reflected lower customer deposits and deferred revenue and higher inventory and receivables. Investing activities used $0.289 million; financing activities provided $0.391 million, including $0.715 million from employee-plan share issuance, partly offset by credit-line repayments.
Changes and outlook
- The company returned to annual profitability after losses in FY2013 and FY2012, while sales shifted toward wafer-level products: that category represented approximately 42% of FY2014 sales versus 31% in FY2013.
- Backlog fell to $6.0 million at May 31, 2014 from $9.1 million a year earlier. Management cautioned that orders may be rescheduled or cancelled, so backlog may not predict future sales.
- Management expected cash, operating cash flows and the credit facility to cover working-capital and capital-equipment needs through FY2015. It gave no specific revenue or earnings forecast; financing after FY2015 could be needed depending on growth and profitability.
- The next-generation FOX system was under development with customer support, and the company said it had received its first production order. Completion was expected in calendar 2014. Management also planned enhancements to ABTS products.
Risks, contingencies and notable items
- Customer concentration is substantial: Texas Instruments, Spansion and Micronas represented approximately 40%, 30% and 12% of FY2014 sales, respectively; the five largest customers accounted for about 90%.
- Sales depend on a small number of high-value equipment orders and cyclical semiconductor capital spending. Customer cancellations, delayed shipments, qualification issues or collection problems could materially affect results.
- Other risks include intense competition and pricing pressure, FOX and ABTS product acceptance and execution, reliance on sole- or limited-source suppliers, inventory obsolescence, foreign-exchange exposure, and international operations. The company did not hedge currency risk.
- The company had $1.491 million of supplier purchase obligations due within 12 months and $0.696 million of operating lease commitments. It disclosed no material pending legal proceedings; indemnification exposure could not be quantified. A full valuation allowance was maintained against deferred tax assets.
- Management stated that disclosure controls and internal control over financial reporting were effective as of May 31, 2014. The independent auditor issued an unqualified opinion on the financial statements; it did not provide an internal-control attestation.
Important facts for investors to verify
- Whether wafer-level sales momentum and the next-generation FOX system translate into repeat production orders and sustainable margins.
- Current customer concentration, order timing, backlog conversion and receivable collectability, especially given the large shares attributable to three customers.
- Cash burn, inventory levels, credit-line availability and terms following the August 2014 extension; assess funding needs beyond FY2015.
- Whether the FY2014 gross-margin improvement from previously written-down materials is repeatable, and whether inventory reserves or warranty costs may rise.
- Potential dilution from equity compensation and share issuance; common shares outstanding were 11.203 million at May 31, 2014 and 11,465,718 at July 31, 2014.